Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
Year: 2019
Type: erratum
Abstract: The original version of this Article omitted from the Author Contributions statement that 'R.S. and J.G.R contributed equally to this work.' This has been corrected in both the PDF and HTML versions of the Article.
Source: Nature Communications
Authors: Jennifer L. Caswell-Jin, Katherine McNamara, Johannes G. Reiter, Ruping Sun, Zheng Hu, Zhicheng Ma, Jie Ding, Carlos J. Suarez, Susanne Tilk, Akshara Raghavendra, Victoria Forte, Suet-Feung Chin, Helen Bardwell, Elena Provenzano, Carlos Caldas, Julie Lang, Robert West, Debu Tripathy, Michael F. Press, Christina Curtis
Institutions: Stanford Medicine, Stanford University, Stanford Cancer Institute, The University of Texas MD Anderson Cancer Center, Maimonides Medical Center, USC Norris Comprehensive Cancer Center, University of Cambridge, Cancer Research UK, Cambridge University Hospitals NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, University of Southern California
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,200
OpenAlex ID: W2947346403